Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human immune cells.

The immediate reaction to the Colossal Biosciences’ claims from a broad section of the scientific community was highly ...

CASGEVY became the world's first genome editing therapy to receive marketing authorization, beginning with the United Kingdom ...

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle ...

Newco Brink Therapeutics SAS is poised to work on the next chapter in genome editing after raising €3.5 million (US$4 million) in seed funding to discover and develop programmable recombinase enzymes.

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

A US bio firm has announced the "rebirth" of an extinct carnivore called the dire wolf by using genome editing technology.

The Workshop on Genome Editing Tool Developments and Clinical Applications (#HKCRISPR25) was successfully held at the Hong ...

The Birbal Sahni Institute of Palaeosciences (BSIP) in the city, in collaboration with the Zoological Survey of India (ZSI), ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

ToolGen commences legal action in UK court over Vertex's genome editing therapy, CASGEVY ®Seeks to expand licensing of its proprietary CRISPR RNP technologySEOUL, South Korea, April 21, 2025 /PRNewswi ...